Wegovy Injection vs Wegovy Tablets

Tablets or injections: what changes in everyday life?

A daily tablet can remove the needle, but it adds a daily task. The right option depends on an individual clinical assessment, your other medicines, tolerability, cost and a routine you can manage.

Are the tablets approved in the UK?

MHRA authorised Wegovy tablets on 11 June 2026 and Foundayo on 10 August 2026. For weight management, both approvals cover adults with a BMI of at least 30, or at least 27 with a weight-related health condition, alongside diet and activity. Meeting that threshold does not establish that a medicine is suitable for you. A prescription and individual assessment are required.

UK authorisation is separate from NHS funding, a provider offering treatment and stock at your prescribed strength. These sources do not confirm a particular provider’s current supply. Read the NHS access guide and ask your prescribing service to confirm availability before relying on an offer.

Which gives better results or fewer side effects?

A headline percentage from one trial cannot rank tablets against injections or another pill. Check the population, dose, duration, comparator, dropouts and how missing data were handled. Trial averages are not personal forecasts. The oral-semaglutide evidence guide explains the Wegovy tablet result in context; the Foundayo guide covers that different medicine. A tablet does not remove gastrointestinal or other medicine risks.

Can I switch from an injection?

Ask the prescribing service for a written plan: the last dose of the current medicine, when the next medicine starts, the prescribed strength and the review date. Do not calculate a tablet dose from an injection dose, overlap medicines or restart after a break on your own. Wegovy tablets and Rybelsus are different licensed products and should not be treated as interchangeable.

What will it cost after the introductory month?

Ask for a written quote for the prescribed dose in month one and the anticipated dose in month four. Include the number of tablets or treatment days, consultation and review fees, delivery, ongoing support, cancellation terms and what happens if treatment is unsuitable or stock is unavailable. Compare equal treatment periods; a starting price is not the ongoing cost.

Use the first-month tablet plan, including missed doses, shift work and questions for your pharmacist.

Open My Timber’s Today screen and look for “Your tablet routine”. If these tablets have already been prescribed for you, optional health tracking lets you save a routine, return for a first-week check-in and say whether a practical step helped. You can use routine support when treatment was arranged elsewhere. Saving a check-in does not contact a clinician; nobody monitors it for symptoms. Medicine decisions stay with your prescribing service.

For everyday support, use food and meal planning and manageable movement and starting steps.

Sources: MHRA: Wegovy tablets authorised, 11 June 2026; MHRA: Foundayo authorised, 10 August 2026; UK Wegovy tablet leaflet, revised June 2026; UK Foundayo leaflet, revised August 2026.

Practical section added and its linked sources checked 6 October 2026 by the SHIFT editorial team. These are general examples, not a personal diet, exercise or treatment prescription. Independent clinical review is not claimed.